Yamada S, Kai A, Kudoh Y
Department of Microbiology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.
J Clin Microbiol. 1994 Apr;32(4):955-9. doi: 10.1128/jcm.32.4.955-959.1994.
Eight cases of hemolytic-uremic syndrome in which no pathogens were isolated were diagnosed serologically by a passive hemagglutination assay and a verotoxin (VT; Shiga-like toxin) enzyme-linked immunosorbent assay (ELISA). The passive hemagglutination assay employed formalinized sheep erythrocytes sensitized with soluble native antigen or heat-treated antigen (lipopolysaccharide [LPS]) from Escherichia coli O26, O111, O128, and O157 or flagellar antigen of nine different H serogroups of E. coli: H2, H7, H8, H10, H11, H12, H18, H19, and H25. All patients had antibodies against the native antigen and/or the LPS of E. coli O157, but positive agglutination with H7 was observed only in one patient. In the VT-ELISA with plates coated with purified VT 1 or VT 2, antibody against VT 2 was observed in the sera of five of six patients examined, but none of the patients possessed VT 1 antibody. These results indicate that the causative pathogen in these eight hemolytic-uremic syndrome cases is likely to be VT-producing E. coli O157. The passive hemagglutination assay described here is a very sensitive, simple, and rapid method. This assay is highly recommended for the serological diagnosis of VT-producing E. coli infections, particularly in patients infected by serogroup O157 strains. Furthermore, the VT-ELISA is useful in studying the role of VT in hemolytic-uremic syndrome.
8例未分离出病原体的溶血尿毒综合征病例通过被动血凝试验和一种vero毒素(VT;志贺样毒素)酶联免疫吸附测定(ELISA)进行血清学诊断。被动血凝试验采用用来自大肠杆菌O26、O111、O128和O157的可溶性天然抗原或热处理抗原(脂多糖[LPS])或9种不同大肠杆菌H血清群(H2、H7、H8、H10、H11、H12、H18、H19和H25)的鞭毛抗原致敏的甲醛化绵羊红细胞。所有患者均有针对大肠杆菌O157天然抗原和/或LPS的抗体,但仅1例患者观察到与H7的阳性凝集反应。在用包被有纯化VT 1或VT 2的酶标板进行的VT-ELISA中,在检测的6例患者中的5例血清中观察到针对VT 2的抗体,但所有患者均无VT 1抗体。这些结果表明,这8例溶血尿毒综合征病例的致病病原体很可能是产VT的大肠杆菌O157。本文所述的被动血凝试验是一种非常灵敏、简单且快速的方法。强烈推荐该试验用于产VT的大肠杆菌感染的血清学诊断,特别是对于感染O157血清群菌株的患者。此外,VT-ELISA在研究VT在溶血尿毒综合征中的作用方面很有用。